Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
yeah, I was still comparing some bonds. There are some really good 30 yr. US bonds available on the secondary market and a really good Israeli 30 yr bond available on the secondary market as well. U.S. vs. Brazil is very realistic in the Semi-finals, as I think U.S. can beat Ghana and then S. Korea/Uruguay.
oh gee, lots of stuff happened today, where to begin... First I woke up, then I made some coffee, then I ate a croissant while drinking the coffee, but I swallowed the piece of croissant in my month before taking in a mouthful of coffee, after I was done eating the croissant I answered some telephone calls, then I checked my e-mail, then I checked the markets, then I picked up my issue of WSJ, then I read my Wall Street Journal, then I checked the markets again, then I turned on the TV, then I saw the end of the Portugal-Brazil match, then I checked the markets again, then drank some more coffee, then I checked the bond markets, then I did some research on some bonds, then I saw your message, then I thought about all the wonderful ways in which I could reply to your message, then I decided and came to a conclusion on how I should answer your message, then I answered your message.
For otcbb stocks, what is presented as the spread is not consistent between brokerages' qoutes and other online sites, such as this one and otcmarkets.com
no, I am going off of this http://ih.advfn.com/p.php?pid=trades&symbol=CTDH which shows that during all of those transactions, the bid was .06 while the ask was .1045, If someone was selling, the transaction should be .06, if it was buying, the transaction should have been .1045, somehow the stock was trading in between the spread. Do you think perhaps that iHub's 'trade' screen in inaccurate?
nice, take that Dracula!
any idea when we are getting our 'dividend shares' for the spin off and at what ratio to our CTDH shares?
just wondering how is the seller getting fills @ .075 when the bid is .06 and ask is .1045?
all that line is saying is that 21 billion dollars in OTC derivatives represents 3.3% of Lehman's assets, which means Lehman has over $636 billion in assets. What makes you think that isn't going all to the creditors? Take into account that the article is not 100% legitimate.
sorry, but what's the 3.3% based on?
any thoughts on how this may impact the stock? http://www.ft.com/cms/s/0/1ec24320-78f3-11df-a312-00144feabdc0.html?referrer_id=yahoofinance&ft_ref=yahoo1&segid=03058 & the update http://www.reuters.com/article/idCNLDE65F0ZN20100616?rpc=44
so it's not really a big deal then?
assuming for a moment that you are correct, the next question is, what are you going to do about it?
dang, $50-$100 was more fun!
mind explaining your calculations on how you arrived at $50-$100 per share? not saying I wouldn't mind it happening though :)
nice, maybe you can do a ppm with ctd to pay for the c-GMP plant then; they mentioned they plan on issuing more shares to pay for it anyways http://investorshub.advfn.com/boards/read_msg.aspx?message_id=50986240
OK, so your saying that employee stock compensation was adjusted in a manner that impacted cash flow the same as how depreciation adjustments impact cash flow. Thanks for clearing that up, it's been needling me for some time.
My main point though is that I think CTDH will get attention/more attention and the stock will see held gains once it has positive net income after expenses. I think that can be made achievable with the orphan designation benefits and the c-GMP plant, which means more time needs to pass. With this in mind I'm thinking that a 1-2 year time frame is reasonable.
easy to read version, use yahoo! finance. http://finance.yahoo.com/q/is?s=CTDH.OB+Income+Statement&annual shows net loss of $193,000 (scroll to bottom of page to see final result after expenses are deducted from income)
then switch to cash flow: http://finance.yahoo.com/q/cf?s=CTDH.OB+Cash+Flow&annual The net loss of $193,000 is being offset by adjustments of approximately $302,000, which is why the total positive cash flow (approximately $108,000) is due to adjustments only. Positive total cash flow needs to be due to net income, not adjustments as it is now. To take a closer look at the adjustments go here: http://www.sec.gov/Archives/edgar/data/922247/000092224710000002/ctdh10k2009a.txt One question that comes to mind is why are they including the $255,388 of 'Stock compensation to employees' as part of their 'Adjustments to reconcile net loss to net cash provided by operating activities'? The company made money by paying stock to it's employees? This doesn't seem right as compensation is a company expense, not a profit. Perhaps that line in the report is simply worded poorly. If this was excluded, total operations for the year would have been negative.
alright, thanks
OK, the Squeeze Price Trigger, why that price? The entity that is issuing the trigger alert, how does it itself know that the stock is being shorted. Additionally, the it's better to offer some sort of evidence that the stock went from .08 to .09 based on a short squeeze instead of simply more shares being actively bought than actively sold. Please offer some sort of evidence, the debate on whether a stock is going down due to shorting or non-shorting selling is very interesting and important. Right now I believe stocks go down more due to actual selling than shorting based on pure volume, but I would like to see any support for the opposite side of the argument.
absolutely, exciting time to be able to get into a stock at a low price with a substantial future. This stock has 'a story', now we just need numbers to flesh it out.
I don't believe that this stock can be shorted in the first place though. It needs to be allowed to be bought on margin first, and brokerages don't allow these types of stocks or stocks at this price level to be bought on margin.
thanks. At this point my thought is that CTD needs to post profitable cash flow based on revenue instead of Adjustments to Net Income, which was $301,258, while cash flow from actual operating activities was a loss, ($193,127). Revenue did grow to $623,874 but expenses grew to $824,809 (when the investment income of $7,808 is included the net loss before taxes is reduced to $193,127 from $200,935). I am excited to see what will happen to the stock after the company is able to have a profitable quarter based on revenue. Institutions should have an easier time getting into this stock at that point. Best of a worst case scenario though is that the company would continue to have profitable quarters, the stock not go up due to lack of institutional involvement, but the company use that money to eventually pay some sort of one time dividend or offer an attractive stock buyback. All of this would take time of course, but as long as CTD's fundamentals remain intact, there is reason to hold on the the stock. I am giving this a minimum of two years as the plant should be finished by the end of the year and then I would like to see a full year's results of having the plant, which should reduce costs, and any of the benefits that the orphan drug designation contributed to the company.
ok, what kind of news announcement would you like, an announcement that they got FDA orphan drug approval perhaps?
with that in mind, perhaps someone wouldn't want to initiate a large position all at once then, meaning large volume won't occur in the first place because the buyer doesn't want to influence the price of the stock individually, just to see the stock drift back lower.
A small float can be a problem if you have a substantial position and want to hit the bid to take profits all at once.
yes, I saw that too, just wondering if anyone had any thoughts on it since it means dilution and some people mentioned before that CTD doesn't usually dilute.
in terms of LEHMQ, what do you think the likely hood is that they will cancel the old shares and simply issue new shares as LEHMV? http://www.sec.gov/investor/pubs/bankrupt.htm
nice move on decent volume. news?
not just today, but yesterday's price action as well. As for painting the tape, that was yesterday's very last transaction for 500 shares taking .124
not just trades below .08-.09 support my conclusion, since the news was released most transaction were those that have been hitting the bid, meaning actively selling, very few transactions are those actually taking the offer, meaning actively buying. Price at this point is just parties getting more for their sale when the stock was above .10 than below .10
Oh, in addition, why it isn't holding .10; my take is that players who were only in it for a pop based on the orphan designation announcement are getting out now that they see that the stock hasn't yet cleared any previous resistances. It's understandable since their reasoning for entering their position did not yield the result they were looking for. Makes sense on their time frame. Personally though I feel that since there is no fundamental change to the company, there is no reason to exit if you have a long term horizon.
it's a good question and there are many possible answers. First and most likely is that there is not enough exposure for the stock and it needs to be put on more peoples'/institutions' radar. Even though the press releases are a good start, the company can do something about this though to increase its exposure.
ask an easy question, get an easy answer
once there's signs that the company would be in the position and it is a likely hood that it can/will pay dividends reasonably in the future, that's when you will see institutions come in. Before that, the stock is at the mercy of speculators.
means no buyer interest
management keeps mentioning the cGMP production facility and the need to acquire financing to complete its construction. Based on that, I am expecting either some type of debt to be taken or more shares to be offered. Of those two options do you have a preference or do you see a third way to finance it in some way?
just broke .09, lets see if it can hold...
congrats? not really a good sign that you could in the first place though...
It's official. Type in Hydroxy-Propyl-Beta-Cyclodextrin into the 'product name' field, and you will see that it was designated 5-17-2010 http://www.accessdata.fda.gov/scripts/opdlisting/oopd/index.cfm
Director MIGLIOZZI JOSEPH J bought 50,000 shares on May 10th 2010 @ .07 per share. Finally some sort of positive development!